CNTX
Context Therapeutics Inc.
There isn't enough reported data to score CNTX yet.
CNTX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Strong |
CNTX's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
CNTX PE Valuation
CNTX has no meaningful PE right now: it lost money over the past year.
CNTX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| -- | |
| -- | |
| Limited | |
| Low |
Analysts expect CNTX's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
CNTX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$0.91 | +$0.39 |
| Q2 2024 | -$1.06 | +$0.11 |
| Q1 2024 | -$1.33 | -$0.22 |
| Q4 2023 | -$1.50 | -$0.57 |
CNTX is still losing money, but far less than before: $0.46 per share over the past year, against $1.50 at its worst in late 2023.
CNTX Quarterly Revenue
CNTX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.6M | -$588 |
| Q2 2026 | -$7M | -$1.2M |
| Q1 2026 | -$11.5M | -$6.4M |
| Q4 2025 | -$8.9M | -$4M |
| Q2 2025 | -$5.8M | -$2.5M |
| Q1 2025 | -$5.1M | -$701.7K |
| Q4 2024 | -$4.9M | +$2.3M |
| Q2 2024 | -$3.4M | +$1.3M |
CNTX has burned cash in almost every quarter: −$34M over the past year, against −$22M the year before.
CNTX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -1.5K shares |
| 3 years | +496% | +79.2M shares |
CNTX has 95M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CNTX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2021 | -0.3x | Net Cash |
| Q4 2020 | 0.8x | Very low |
CNTX has more cash than debt.
CNTX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.1 | Oversold |
| Stochastic | 2.5 | Oversold |
CNTX's weekly RSI is 29 (oversold) and its Stochastic is 3 (oversold).
CNTX PE vs Healthcare Sector
CNTX has no meaningful PE right now: it lost money over the past year.
CNTX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.25 | 20% below |
| 20 week MA | $0.41 | 51% below |
| 50 week MA | $1.38 | 86% below |
| 100 week MA | $1.13 | 82% below |
| 200 week MA | $1.24 | 84% below |
CNTX is in a downtrend: it's below all five of its weekly moving averages, and 84% below its 200-week average.
CNTX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $6.99 | $3.22 | -54% |
| 2022 | $3.22 | $0.63 | -80% |
| 2023 | $0.63 | $1.13 | +79% |
| 2024 | $1.13 | $1.10 | -2.7% |
| 2025 | $1.10 | $1.13 | +2.7% |
| 2026 YTD | $1.13 | $0.20 | -82% |
CNTX has finished lower in three of the last five years. It's down 82% so far in 2026.